|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.15 CNY | +0.50% |
|
-6.00% | -8.34% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.49 | +51.63% | 8 | ||||||
| 62.03 | +104.88% | 16 | ||||||
| 5.061 | +76.93% | 17 | ||||||
| 2,979 | +27.72% | 10 | ||||||
| 33.72 | +69.42% | 12 | ||||||
| 350.38 | +44.22% | 8 | ||||||
| 125.87 | +31.8% | 9 | ||||||
| 47 | +10.82% | 6 | ||||||
| 35.56 | +4.23% | 8 | ||||||
| 79.67 | +20.07% | 9 | ||||||
| 1,168.71 | +38.4% | 7 | ||||||
| 58.31 | +31.87% | 7 | ||||||
| 14.86 | +38.77% | 5 | ||||||
| - | 90 | +20.64% | 2 | |||||
| - | 5,350 | +60.42% | 2 | |||||
| 7.833 | +110.01% | 6 | ||||||
| 7.494 | -8.16% | 8 | ||||||
| Average | 614.12 | +43.16% | 8 | ||||||
| Weighted average by Cap. | 483.2 | +60.69% | 12 |
Select your edition
All financial news and data tailored to specific country editions
